Title
Authorize an increase to the total Agreement amount of the Carefusion Medmined-Alaris Agreement (A-13080) of $126,636 to pay for the Integrated Solutions Maintenance for the remaining four (4) years of the agreement term, for a revised total agreement amount not to exceed $1,675,628.
Report
RECOMMENDATION:
It is recommended the Board of Supervisors:
Authorize an increase to the total Agreement amount of the Carefusion Medmined-Alaris Agreement (A-13080) of $126,636 to pay for the Integrated Solutions Maintenance for the remaining four (4) years of the agreement term, for a revised total agreement amount not to exceed $1,675,628.
SUMMARY/DISCUSSION:
On March 22, 2016 the Board of Supervisors approved an Agreement between Carefusion and NMC for a software product called Medmined. The Medmined product is used for surveillance, analytics, benchmarking, alerting and reporting in medication management and infection control at NMC. Then on August 23, 2016 the Board of Supervisors approved Amendment No. 1 to the Carefusion Medmined Agreement to add a software-based intravenous infusion pump product called Alaris. The Alaris IV pumps include software that allows the pumps to be programmed by nurses and physicians to infuse medications at different rates. The software contains libraries of different medications and their infusion parameters. These pumps ensure safety by preventing medications from being infused at rates greater than or less than safe limits.
At the time NMC and Carefusion were negotiating terms and conditions of Amendment No. 1 for the Alaris product, NMC inadvertently omitted the maintenance costs for the Infusion Integrated Solutions for years 2, 3, 4 and 5. Only the first year cost was included in the total amount requested. The annual maintenance cost for Integrated Solutions Maintenance is $28,380 per year (plus tax), therefore, NMC is requesting to increase the total agreement amount by $126,636 for a revised correct total agreement amo...
Click here for full text